First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
17 hedge funds and large institutions have $8.52M invested in First Trust Nasdaq Pharmaceuticals ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% less funds holding
Funds holding: 18 → 17 (-1)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$643K | |
| 2 | +$571K | |
| 3 | +$538K | |
| 4 |
Truist Financial
Charlotte,
North Carolina
|
+$536K |
| 5 |
LPL Financial
San Diego,
California
|
+$233K |
Top Sellers
| 1 | -$652K | |
| 2 | -$402K | |
| 3 | -$62.3K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$17.5K |
| 5 |
JAWM
J. Arnold Wealth Management
Youngstown,
Ohio
|
-$16K |